Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new VIVO (View into Ventricular Onset) system for market release in the United States. VIVO is a pre-procedure planning tool that offers 3-D cardiac mapping to aid in localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to electrophysiology studies. The novel VIVO system uses magnetic resonance imaging (MRI) or a computed tomography (CT) scan along with a standard 12-lead ΕCG to computer-generate color-coded 3-D mapping images of the heart to indicate the area of earliest activation.

Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into the Artis icono angiography system from Siemens Healthineers. The VIST Virtual Patient thus becomes a fully integrated simulation solution for the angio suite, according to the companies. The global partnership between the two companies will allow interventional radiologists, neuroradiologists, and cardiologists to perform vascular and cardiac interventions on a virtual patient inside the angio-suite.